|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2404614 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11184308.2 |
| Europos patento paraiškos padavimo data | 2007-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-06-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 876222 P | 2006-12-20 | US |
| (72) |
Fakhrai, Habib, US
Shawler, Daniel L., US
|
| (73) |
Novarx,
6828 Nancy Ridge Drive, Suite 100, San Diego CA 92121-2635,
US
|
| (54) | Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |